Ingevity Corp (NGVT) Q3 2025 10-Q Quarterly Report
Ingevity Corp (NGVT) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 6, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
Ingevity Corp Q3 2025 10-Q Analysis
Risk Factors
- • Newly added trade policy risk from new U.S. tariffs and Chinese retaliatory measures lowering margins on products sold into China
- • Materially updated operational risk of facility disruptions, including labor strikes with recent CBA expirations and renewals through mid-2025
Ingevity Corp Q3 2025 Quarterly FinancialsXBRL
Revenue
$263M
▼ -30.1% YoY▼ -27.9% QoQ
Net Income
$44M
▲ +140.6% YoY▲ +129.7% QoQ
Gross Margin
46.5%
▲ +1200bp YoY▲ +870bp QoQ
Net Margin
16.5%
▲ +4496bp YoY▲ +5664bp QoQ
ROE
31.5%
Total Assets
$1.8B
EPS (Diluted)
$1.19
▲ +140.3% YoY▲ +129.6% QoQ
Operating Cash Flow
$130M
▲ +178.9% YoY▲ +64.2% QoQ
Source: XBRL data from Ingevity Corp Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on Ingevity Corp
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.